Endophthalmitis caused by Burkholderia cepacia complex (BCC): clinical characteristics, antibiotic susceptibilities, and treatment outcomes

Journal of Ophthalmic Inflammation and Infection

Table 2 Patient characteristics

Patient Characteristics	Case 1	Case 2	Case 3
Age	80 years old	66 years old	62 years old
Gender	Male	Female	Male
Baseline VA	HM	LP	N/A
Presenting VA	HM	LP	LP
Presenting Symptoms	Painful red eye, hypopyon	Painful red eye, hypopyon	Painful red eye, corneoscleral melt
Final VA	NLP	NLP	LP
Eye Removed	Enucleation	Enucleation	Phthisical eye
Preceding Surgery or Event	Repeat PKP + AMT + intravitreal Avastin	GDI	Blunt trauma
Prior Eye Surgery	PCIOL, ExPRESS, GDI	PCIOL	PCIOL
Time from Last Surgery	1 day	2.5 weeks	3 years
Topical Medications	Vancomycin (50 mg/mL) Tobramycin (14 mg/mL) Moxifloxacin Atropine	Vancomycin (50 mg/mL) Tobramycin (14 mg/mL) Prednisolone Moxifloxacin Atropine	Vancomycin (50 mg/mL) Tobramycin (14 mg/mL) Moxifloxacin Prednisolone
Periocular Injections			Subtenon's triamcinolone
Intraocular Injections	Vancomycin Ceftazidime Dexamethasone	Vancomycin Ceftazidime Dexamethasone
Oral Medications	N/A	N/A	Levofloxacin Ciprofloxacin Prednisolone

PCIOL Posterior chamber intraocular lens, n/a Not available, HM Hand motion, LP Light perception, NLP No light perception, VA Visual acuity, PKP Penetrating keratoplasty, AMT Amniotic membrane transplantationm, GDI Glaucoma drainage implant